Donald A. Bergstrom - Dec 27, 2021 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Executive Vice President, Head of Research and Development
Signature
/s/ Brian Adams, as attorney-in-fact
Stock symbol
RLAY
Transactions as of
Dec 27, 2021
Transactions value $
-$21,482
Form type
4
Date filed
12/27/2021, 06:39 PM
Previous filing
Oct 19, 2021
Next filing
Jan 31, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$21.5K -649 -1.42% $33.10 45K Dec 27, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover the reporting person's income tax withholding obligations upon the vesting of 2,188 shares of restricted stock units ("RSUs") on December 26, 2021. The reporting person had no discretion with respect to such sale, which was transacted in accordance with the Issuer's policies regarding the vesting of RSUs.
F2 Includes 28,437 shares underlying RSUs.

Remarks:

Executive Vice President, Head of Research and Development